Videos
Videos

Metabesity 2017: Qualifying Clinical Candidates for Anti Aging Interventions

AFAR Deputy Scientific Director Nir Barzilai, M.D. speaks about the Targeting Aging with Metformin (TAME) trial and the potential for drug interventions to extend healthspan, our years of health as we age. Learn more about the TAME Trial, which AFAR is helping manage, here.



AFAR Honorary Leadership Awarded to Nathaniel David

In July, AFAR presented its 2017 Honorary Leadership Award to Nathaniel “Ned” David, Ph.D. for his dedication to healthy aging and his role in helping advance some of the most significant research discoveries and potential interventions. A biochemist and biotech entrepreneur who has founded four visionary biotech companies, Dr. David co-founded UNITY in 2011 along with three of the leading researchers in the field of cellular senescence, including AFAR grantee Judith Campisi, Ph.D. In his acceptance speech, David spoke passionately about how AFAR’s early support of Campisi’s research has made a major impact on…





BACK TO TOPBACK TO TOP

STAY CONNECTED